Open Access

Deregulation of folate pathway gene expression correlates with poor prognosis in acute leukemia

  • Authors:
    • Jorge Organista‑Nava
    • Yazmín Gómez‑Gómez
    • Oscar del Moral‑Hernandez
    • Berenice Illades‑Aguiar
    • Jazmin Gómez‑Santamaria
    • Ana Bertha Rivera‑Ramírez
    • Mónica Virginia Saavedra‑Herrera
    • Marco Antonio Jimenez‑López
    • Marco Antonio Leyva‑Vázquez
  • View Affiliations

  • Published online on: July 22, 2019     https://doi.org/10.3892/ol.2019.10650
  • Pages: 3115-3127
  • Copyright: © Organista‑Nava et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study analyzed the mRNA expression levels of genes involved in the transport and metabolism of methotrexate (MTX) (RFC1, ABCC1, ABCB1, GGH, FPGS, ATIC, TS, MTHFR, MTRR, MS and MTHFD1) in patients with acute leukemia (AL). The expression levels of the examined genes were analyzed by reverse transcription quantitative polymerase chain reaction (RT‑qPCR) in patients with AL (ALL:50/AML:19) and 66 healthy individuals. The mRNA expression levels of RFC1, MS, MTRR, MTHFR and ABCB1 were decreased (P<0.05), while those of GGH, FPGS, TS and MTHFD1 (P<0.05) were overexpressed in patients with AL. Patients with high mRNA levels of GGH (OR=4.28, 95% CI=1.29‑14.14), TS (OR=7.14, 95% CI 1.84‑27.81), MTHFR (OR=4.81, 95% CI=1.31‑17.64), ABCB1 (OR=4.61, 95% CI=1.33‑15.97) and ABCC1 (OR=5.50, 95% CI=1.12‑27.06) had a higher chance of relapse. Interestingly, high mRNA levels of RFC1 are a protective factor in the risk of AL relapse (OR=0.22, 95% 0.06‑0.80). The results of the present study indicated that deregulation of folate pathway gene expression is associated with poor prognosis in AL and that the expression levels of these markers could serve as novel molecular targets for the treatment of patients with AL.

Related Articles

Journal Cover

September 2019
Volume 18 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Organista‑Nava, J., Gómez‑Gómez, Y., del Moral‑Hernandez, O., Illades‑Aguiar, B., Gómez‑Santamaria, J., Rivera‑Ramírez, A.B. ... Leyva‑Vázquez, M.A. (2019). Deregulation of folate pathway gene expression correlates with poor prognosis in acute leukemia. Oncology Letters, 18, 3115-3127. https://doi.org/10.3892/ol.2019.10650
MLA
Organista‑Nava, J., Gómez‑Gómez, Y., del Moral‑Hernandez, O., Illades‑Aguiar, B., Gómez‑Santamaria, J., Rivera‑Ramírez, A. B., Saavedra‑Herrera, M. V., Jimenez‑López, M. A., Leyva‑Vázquez, M. A."Deregulation of folate pathway gene expression correlates with poor prognosis in acute leukemia". Oncology Letters 18.3 (2019): 3115-3127.
Chicago
Organista‑Nava, J., Gómez‑Gómez, Y., del Moral‑Hernandez, O., Illades‑Aguiar, B., Gómez‑Santamaria, J., Rivera‑Ramírez, A. B., Saavedra‑Herrera, M. V., Jimenez‑López, M. A., Leyva‑Vázquez, M. A."Deregulation of folate pathway gene expression correlates with poor prognosis in acute leukemia". Oncology Letters 18, no. 3 (2019): 3115-3127. https://doi.org/10.3892/ol.2019.10650